Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction
Phase 2
Completed
- Conditions
- MGD-Meibomian Gland DysfunctionMeibomian Gland Dysfunction
- Interventions
- Drug: 0.3% Topical Minocycline OintmentDrug: 1% Topical Minocycline OintmentOther: Topical Vehicle Ointment
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2021-03-05
- Lead Sponsor
- Hovione Scientia Limited
- Target Recruit Count
- 270
- Registration Number
- NCT03888378
- Locations
- ๐บ๐ธ
Clinical site - 13, Mission Hills, California, United States
๐บ๐ธClinical site - 9, Saint Louis, Missouri, United States
๐บ๐ธClinical Site - 18, Largo, Florida, United States
Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea
Phase 2
Completed
- Conditions
- Papulopustular RosaceaRosacea
- Interventions
- Other: Topical Vehicle GelDrug: 1% Topical Minocycline GelDrug: 3% Topical Minocycline Gel
- First Posted Date
- 2017-08-28
- Last Posted Date
- 2019-11-08
- Lead Sponsor
- Hovione Scientia Limited
- Target Recruit Count
- 270
- Registration Number
- NCT03263273
- Locations
- ๐บ๐ธ
Clinical Site - 16, Boise, Idaho, United States
๐บ๐ธClinical Site - 8, Goodlettsville, Tennessee, United States
๐บ๐ธClinical Site - 21, Berlin, New Jersey, United States